Semaglutide fat loss trials also highlight its success, with users losing up to 14.9% of their body weight over 68 weeks, outpacing placebo groups
Stability, compatibility, and degradation profiling of multinutrient aqueous formulations
Later work examined NNMT inhibition combined with dietary changes in obese mice, reporting reductions in body weight, fat mass, and hepatic fat, alongside shifts in gut bacterial populations
Functional Medicine Providers These specialists look at root causes and offer holistic support
Kraus D, Yang Q, Kong D, et al
Certificate of analysis (CoA) available for each batch upon request